Sponsored / Partner Content
Jonathan Kaplan, MD, MPH
CEO
DrWell
San Francisco, CA, United States
Most practices think they understand their medication margins — but very few truly measure them. This session exposes the hidden fragility inside recurring medication revenue. We break down the “$20 vial myth,” uncover the real cost of staff dependency, and reveal how payment leakage and refill drop-off quietly erode profitability. You’ll learn why true COGS extends beyond ingredient cost, how predictability creates durable margin, and why infrastructure — not just a portal — determines whether your program scales or stalls. This is not a sales pitch. It’s a margin clarity conversation.